Ngā hua rapu kaituhi

1

ecancermedicalscience mā Nancy U. Lin

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Targeted Therapies in Brain Metastases mā Nancy U. Lin

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

How we treat HER2-positive brain metastases mā Eleni Stavrou, Eric P. Winer, Nancy U. Lin

I whakaputaina 2021

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes? mā Inês Machado Vaz, Eric P. Winer, Nancy U. Lin

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment mā Ana C. Garrido-Castro, Nancy U. Lin, Kornélia Polyák

I whakaputaina 2019

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis mā Pedro Exman, Robert M. Mallery, Nancy U. Lin, Heather A. Parsons

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

The ethical use of mandatory research biopsies mā Erin M. Olson, Nancy U. Lin, Ian E. Krop, Eric P. Winer

I whakaputaina 2011

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

Effect of Very Small Tumor Size on Cancer-Specific Mortality in Node-Positive Breast Cancer mā Jennifer Y. Wo, Kun Chen, Bridget A. Neville, Nancy U. Lin, Rinaa S. Punglia

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

CNS Metastases in Breast Cancer: Old Challenge, New Frontiers mā Nancy U. Lin, Laleh Amiri‐Kordestani, Diane Palmieri, David J. Liewehr, Patricia S. Steeg

I whakaputaina 2013

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
10

Patterns of recurrence and metastasis in BRCA1/BRCA2‐associated breast cancers mā Yun Song, William T. Barry, Davinia Seah, Nadine Tung, Judy E. Garber, Nancy U. Lin

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models mā Luke Whitesell, Sandro Santagata, Marc L. Mendillo, Nancy U. Lin, David A. Proia, Susan Lindquist

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain? mā Sheheryar Kabraji, Jing Ni, Nancy U. Lin, Shaozhen Xie, Eric P. Winer, Jean J. Zhao

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to Alpelisib mā Felipe Batalini, Stacy Moulder, Eric P. Winer, Hope S. Rugo, Nancy U. Lin, Gerburg M. Wulf

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer mā Nancy U. Lin, Elizabeth B. Claus, Jessica Sohl, Abdul Rab Razzak, Amal Arnaout, Eric P. Winer

I whakaputaina 2008

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab mā Erik M. Olson, Mahmoud Abdel‐Rasoul, J Malý, Christina Wu, Nancy U. Lin, Charles L. Shapiro

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
16

Duration and Toxicity of Adjuvant Trastuzumab in Older Patients With Early-Stage Breast Cancer: A Population-Based Study mā Inês Vaz-Luís, Nancy L. Keating, Nancy U. Lin, Huichuan Lii, Eric P. Winer, Rachel A. Freedman

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population-Based Study mā Inês Vaz-Luís, Nancy U. Lin, Nancy L. Keating, William T. Barry, Eric P. Winer, Rachel A. Freedman

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era mā Erin M. Olson, Julie Najita, Jessica Sohl, Amal Arnaout, Harold J. Burstein, Eric P. Winer, Nancy U. Lin

I whakaputaina 2013

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non–Small Cell Lung Cancer mā Daniel Cagney, Allison Martin, Paul J. Catalano, Paul D. Brown, Brian M. Alexander, Nancy U. Lin, Ayal A. Aizer

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
20

Use and Duration of Chemotherapy in Patients With Metastatic Breast Cancer According to Tumor Subtype and Line of Therapy mā Davinia Seah, Inês Vaz-Luís, Erin Macrae, Jessica Sohl, Georgia Litsas, Eric P. Winer, Nancy U. Lin, Harold J. Burstein

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

ecancermedicalscience mā Nancy U. Lin

Targeted Therapies in Brain Metastases mā Nancy U. Lin

How we treat HER2-positive brain metastases mā Eleni Stavrou, Eric P. Winer, Nancy U. Lin

Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes? mā Inês Machado Vaz, Eric P. Winer, Nancy U. Lin

Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment mā Ana C. Garrido-Castro, Nancy U. Lin, Kornélia Polyák

Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis mā Pedro Exman, Robert M. Mallery, Nancy U. Lin, Heather A. Parsons

The ethical use of mandatory research biopsies mā Erin M. Olson, Nancy U. Lin, Ian E. Krop, Eric P. Winer

Effect of Very Small Tumor Size on Cancer-Specific Mortality in Node-Positive Breast Cancer mā Jennifer Y. Wo, Kun Chen, Bridget A. Neville, Nancy U. Lin, Rinaa S. Punglia

CNS Metastases in Breast Cancer: Old Challenge, New Frontiers mā Nancy U. Lin, Laleh Amiri‐Kordestani, Diane Palmieri, David J. Liewehr, Patricia S. Steeg

Patterns of recurrence and metastasis in <i>BRCA1/BRCA2</i>‐associated breast cancers mā Yun Song, William T. Barry, Davinia Seah, Nadine Tung, Judy E. Garber, Nancy U. Lin

HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models mā Luke Whitesell, Sandro Santagata, Marc L. Mendillo, Nancy U. Lin, David A. Proia, Susan Lindquist

Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain? mā Sheheryar Kabraji, Jing Ni, Nancy U. Lin, Shaozhen Xie, Eric P. Winer, Jean J. Zhao

Response of Brain Metastases From <i>PIK3CA</i>-Mutant Breast Cancer to Alpelisib mā Felipe Batalini, Stacy Moulder, Eric P. Winer, Hope S. Rugo, Nancy U. Lin, Gerburg M. Wulf

Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer mā Nancy U. Lin, Elizabeth B. Claus, Jessica Sohl, Abdul Rab Razzak, Amal Arnaout, Eric P. Winer

Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab mā Erik M. Olson, Mahmoud Abdel‐Rasoul, J Malý, Christina Wu, Nancy U. Lin, Charles L. Shapiro

Duration and Toxicity of Adjuvant Trastuzumab in Older Patients With Early-Stage Breast Cancer: A Population-Based Study mā Inês Vaz-Luís, Nancy L. Keating, Nancy U. Lin, Huichuan Lii, Eric P. Winer, Rachel A. Freedman

Factors Associated with Early Mortality Among Patients with <i>De Novo</i> Metastatic Breast Cancer: A Population-Based Study mā Inês Vaz-Luís, Nancy U. Lin, Nancy L. Keating, William T. Barry, Eric P. Winer, Rachel A. Freedman

Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era mā Erin M. Olson, Julie Najita, Jessica Sohl, Amal Arnaout, Harold J. Burstein, Eric P. Winer, Nancy U. Lin

Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non–Small Cell Lung Cancer mā Daniel Cagney, Allison Martin, Paul J. Catalano, Paul D. Brown, Brian M. Alexander, Nancy U. Lin, Ayal A. Aizer

Use and Duration of Chemotherapy in Patients With Metastatic Breast Cancer According to Tumor Subtype and Line of Therapy mā Davinia Seah, Inês Vaz-Luís, Erin Macrae, Jessica Sohl, Georgia Litsas, Eric P. Winer, Nancy U. Lin, Harold J. Burstein

Ngā hua rapu - Nancy U. Lin

ecancermedicalscience mā Nancy U. Lin

Targeted Therapies in Brain Metastases mā Nancy U. Lin

How we treat HER2-positive brain metastases mā Eleni Stavrou, Eric P. Winer, Nancy U. Lin

Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes? mā Inês Machado Vaz, Eric P. Winer, Nancy U. Lin

Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment mā Ana C. Garrido-Castro, Nancy U. Lin, Kornélia Polyák

Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis mā Pedro Exman, Robert M. Mallery, Nancy U. Lin, Heather A. Parsons

The ethical use of mandatory research biopsies mā Erin M. Olson, Nancy U. Lin, Ian E. Krop, Eric P. Winer

Effect of Very Small Tumor Size on Cancer-Specific Mortality in Node-Positive Breast Cancer mā Jennifer Y. Wo, Kun Chen, Bridget A. Neville, Nancy U. Lin, Rinaa S. Punglia

CNS Metastases in Breast Cancer: Old Challenge, New Frontiers mā Nancy U. Lin, Laleh Amiri‐Kordestani, Diane Palmieri, David J. Liewehr, Patricia S. Steeg

Patterns of recurrence and metastasis in <i>BRCA1/BRCA2</i>‐associated breast cancers mā Yun Song, William T. Barry, Davinia Seah, Nadine Tung, Judy E. Garber, Nancy U. Lin

HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models mā Luke Whitesell, Sandro Santagata, Marc L. Mendillo, Nancy U. Lin, David A. Proia, Susan Lindquist

Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain? mā Sheheryar Kabraji, Jing Ni, Nancy U. Lin, Shaozhen Xie, Eric P. Winer, Jean J. Zhao

Response of Brain Metastases From <i>PIK3CA</i>-Mutant Breast Cancer to Alpelisib mā Felipe Batalini, Stacy Moulder, Eric P. Winer, Hope S. Rugo, Nancy U. Lin, Gerburg M. Wulf

Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer mā Nancy U. Lin, Elizabeth B. Claus, Jessica Sohl, Abdul Rab Razzak, Amal Arnaout, Eric P. Winer

Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab mā Erik M. Olson, Mahmoud Abdel‐Rasoul, J Malý, Christina Wu, Nancy U. Lin, Charles L. Shapiro

Duration and Toxicity of Adjuvant Trastuzumab in Older Patients With Early-Stage Breast Cancer: A Population-Based Study mā Inês Vaz-Luís, Nancy L. Keating, Nancy U. Lin, Huichuan Lii, Eric P. Winer, Rachel A. Freedman

Factors Associated with Early Mortality Among Patients with <i>De Novo</i> Metastatic Breast Cancer: A Population-Based Study mā Inês Vaz-Luís, Nancy U. Lin, Nancy L. Keating, William T. Barry, Eric P. Winer, Rachel A. Freedman

Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era mā Erin M. Olson, Julie Najita, Jessica Sohl, Amal Arnaout, Harold J. Burstein, Eric P. Winer, Nancy U. Lin

Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non–Small Cell Lung Cancer mā Daniel Cagney, Allison Martin, Paul J. Catalano, Paul D. Brown, Brian M. Alexander, Nancy U. Lin, Ayal A. Aizer

Use and Duration of Chemotherapy in Patients With Metastatic Breast Cancer According to Tumor Subtype and Line of Therapy mā Davinia Seah, Inês Vaz-Luís, Erin Macrae, Jessica Sohl, Georgia Litsas, Eric P. Winer, Nancy U. Lin, Harold J. Burstein

Ngā utauta rapu:

Ngā marau whai pānga